Pritelivir

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NamePritelivir
Drug Alias Name普特利韦pritelivirumpritelivir普瑞利韦BAY-57-1293 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA helicase/primase complex inhibitors
TargetsDNA helicase/primase complex
Therapy Area/IndicationsHerpes LabialisHerpes SimplexHerpes Genitalis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[16] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesRottendorf Pharma GmbhAiCuris Anti-infective Cures AGBeijing Medpace Ltd
Inactive CompaniesN/A
Active IndicationsHerpes Simplex
Inactive IndicationsHerpes LabialisHerpes Genitalis

Other Information

ATC CodeN/A
Related LinksN/A